Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

6.72
BATS BZX Real-Time Price
As of 11:06am ET
 +0.03 / +0.45%
Today’s Change
1.51
Today|||52-Week Range
8.84
+229.41%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close6.69
Today’s open6.66
Day’s range6.66 - 6.82
Volume87,558
Average volume (3 months)3,400,517
Market cap$750.8M
Dividend yield--
Data as of 11:06am ET, 09/26/2017

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+49.85%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...0.000.00%
NTLAIntellia Therapeutic...-0.16-0.67%
BOLDAudentes Therapeutic...-0.37-1.28%
AMAGAMAG Pharmaceuticals...+0.07+0.41%
Data as of 11:03am ET, 09/26/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts